STunning in Acute Myocardial Infarction - BAS
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 120 participants.
Also called NCT06562582
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT06562582
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT06562582. Randomized; no masking; primary purpose treatment. Start 2025-01-06 (actual); primary completion 2027-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- STunning in Acute Myocardial Infarction - BAS
- Acronym
- STAMI-BAS
- Condition
- Myocardial Infarct
- Intervention (Drug)
- Bisoprolol Oral Tablet
- Intervention (Drug)
- Ramipril Oral Product
- Intervention (Drug)
- Dapagliflozin Oral Product
- Lead sponsor
- Vastra Gotaland Region
Record details
- Record id
cardio:ct-nct06562582- Content hash
87bd89d721db4492fb86111d0021e7d0e1c93fedbafe411bdccb1fe693413e68